New York State Common Retirement Fund
CNTX icon

New York State Common Retirement Fund’s Context Therapeutics CNTX Stock Holding History

New York State Common Retirement Fund’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.9K Buy
+135,300
New +$274K ﹤0.01% 2830

Other funds holding CNTX

PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

New York State Common Retirement Fund's CNTX Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Context Therapeutics (CNTX) in Q2 2026: 135,300 shares worth $74.9K. The stake represents ﹤0.01% of the portfolio and ranks #2830 among its holdings.

7 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

  • New York State Common Retirement Fund held 135,300 shares of Context Therapeutics worth $74.9K as of Q2 2026.
  • Context Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
  • Context Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2830 holding.
  • 7 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.